The Ritz-Carlton, 1150 22nd St NW
Washington, DC 20037
Thank you to all who attended the 10th Friends of Cancer Research Annual Meeting. To read a full event recap, including links to panel whitepapers and slides, please Click HERE.
Final Agenda
8:30am – Welcome
Ellen Sigal, Chair & Founder, Friends of Cancer Research
Jeff Allen, President & CEO, Friends of Cancer Research
8:35am – Breakfast Keynote – Facebook Live Link
Scott Gottlieb, Commissioner, U.S. FDA
9:00am – Panel 1 – Access the Panel Video via Facebook Live
Capitalizing on the Totality of Evidence to Streamline Approvals for Supplemental Indications
- Moderator: George Demetri, Dana-Farber Cancer Institute, Harvard Medical School
- Shanthi Ganeshan, Novartis Pharmaceuticals
- Marian Johnson-Thompson, Komen Patient Advocate
- Amy McKee, U.S. FDA
- Pratik Multani, Ignyta
- Jordan Schecter, Janssen
11:00am – Panel 2 – Access the Panel Video via Facebook Live
Data Generation to Support Cross-labeling of Indications for Combination Products
- Moderator: Kenneth Anderson, Dana-Farber Cancer Institute, Harvard Medical School
- Roger Dansey, Merck
- Ann Farrell, U.S. FDA
- James Myers, U.S. FDA
- Jim Omel, Cancer Research Advocate
- Marc Scheineson, Alston & Bird LLP
12:45pm – Lunch
1:45pm – Lunch Conversation – Facebook Live Link
- Richard Pazdur, U.S. FDA
- Norman “Ned” Sharpless, NCI
- Ellen Sigal, Friends of Cancer Research
2:15pm – Panel 3 – Access the Panel Video via Facebook Live
Updating Outdated Product Labels
- Moderator: Jeff Allen, Friends of Cancer Research
- Angela Green, Memorial Sloan Kettering Cancer Center
- Linda House, Cancer Support Community
- Rachel Sher, Association for Accessible Medicines
- Josephine Torrente, Hyman, Phelps & McNamara, PC
- Janet Woodcock, U.S. FDA
4:00pm – Closing Remarks
Jeff Allen, Friends of Cancer Research
